Australian Clinical Labs Limited

ACL

AU0000148496

Healthcare Facilities & Services

Market Closed - Australian S.E. Other stock markets 07:10:23 14/06/2024 BST			5-day change	1st Jan Change
2.46 ^AUD	+1.65%		+7.42%	-14.88%

05-28	Ord Minnett Starts Australian Clinical Labs at Buy, Price Target is AU$3.50	MT
05-21	Australian Clinical Expects Fiscal 2024 Earnings to Fall at Lower End of Forecast	MT

Australian Clinical Labs Limited Approves Appointment of Pitcher Partners as Auditor

October 27, 2021 at 01:37 am

Australian Clinical Labs Limited at its Annual General Meeting, approved the appointment of Pitcher Partners as Auditor.

Latest news about Australian Clinical Labs Limited

Ord Minnett Starts Australian Clinical Labs at Buy, Price Target is AU$3.50	05-28	MT
Australian Clinical Expects Fiscal 2024 Earnings to Fall at Lower End of Forecast	05-21	MT
Australia shares inch lower as miners weigh; GDP data in focus	03-05	RE
Australian Clinical Labs Falls 11% After Trimming Interim Dividend on Lower H1 FY24 EPS	02-28	MT
Transcript : Australian Clinical Labs Limited, H1 2024 Earnings Call, Feb 28, 2024	02-28
Australian Clinical Labs Slashes Interim Dividend as Underlying H1 FY24 EPS Falls 49%	02-27	MT
Australian Clinical Labs Posts H1 FY24 Revenue Down 6.4% to AU$337.3 Million; Underlying Diluted EPS of AU$0.0511	02-27	MT
Australian Clinical Labs Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-27	CI
Australian Clinical Labs Gets Regulator Approval to Withdraw Healius Takeover Offer	12-26	MT
Australian Clinical Labs Limited cancelled the acquisition of Healius Limited from Tanarra Capital Australia Pty Ltd, Perpetual Investment Management Ltd and others.	12-21	CI
Australian shares end higher on miners, Fed rate pivot	12-15	RE
US Fed's Dovish Stance Lifts Australian Shares	12-15	MT
Australian Clinical Labs Intends to Withdraw Proposed Healius Takeover	12-15	MT
Competition Regulator Denies Australian Clinical Labs’ Proposed Takeover of Healius	12-15	MT
Australia shares hit over 4-mth high on boost from commodities, banks stocks	12-15	RE
Australian Clinical Labs to withdraw $1 billion offer for Healius; stocks fall	12-14	RE
Transcript : Australian Clinical Labs Limited - Shareholder/Analyst Call	22/10/23
Australian Clinical Labs Fulfills Conditions for Healius Takeover	10/10/23	MT
Australia Inc roiled by string of cyber attacks since late 2022	29/09/23	RE
Australian Clinical Labs Defers Healius Acquisition EGM	14/09/23	MT
Australian Clinical Labs Chairman to Resume Role	12/09/23	MT
Australian Clinical Labs Limited canceled the acquisition of Healius Limited	04/09/23	CI
Australian Clinical Labs Limited Announces Appointment of Christine Bartlett as Non-Executive Director	23/08/23	CI
Australian Clinical Labs Lowers Final Dividend as Fiscal 2023 Profit Falls; Shares Plunge 14%	22/08/23	MT
Transcript : Australian Clinical Labs Limited, 2023 Earnings Call, Aug 22, 2023	22/08/23

Chart Australian Clinical Labs Limited

Duration

Period

More charts

Australian Clinical Labs Limited is a private provider of pathology services. Its laboratories perform a range of pathology tests each year for a range of clients, including doctors, specialists, patients, hospitals, and corporate clients. It performs a range of services for doctors, patients, and corporate clients, including routine pathology tests, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology and cytopathology, hematology, allergy and immunology, serology and microbiology, infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing. Its specialist services include molecular cancer services, obstetrics and gynecology, pharmacogenetic testing, gastroenterology, and hospital services. It has operations in Victoria, New South Wales, Western Australia, South Australia, Queensland, and the Northern Territory.

Sector

Healthcare Facilities & Services

Calendar

21/08/2024 - Q4 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Australian Clinical Labs Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

2.46 AUD

Average target price

3.096 AUD

Spread / Average Target

+25.86%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
AUSTRALIAN CLINICAL LABS LIMITED	-14.88%	322M
HCA HEALTHCARE, INC.	+24.31%	89.29B
CVS HEALTH CORPORATION	-23.87%	76.62B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+3.24%	26.87B
LABCORP HOLDINGS INC.	-12.50%	16.56B
QUEST DIAGNOSTICS INCORPORATED	+0.14%	15.39B
TENET HEALTHCARE CORPORATION	+82.00%	13.62B
NATERA, INC.	+75.59%	13.61B
PURE HEALTH HOLDING	-24.56%	12.67B
UNIVERSAL HEALTH SERVICES, INC.	+23.02%	12.59B

Other Healthcare Facilities & Services